Moneycontrol PRO
you are here: HomeNewsBusiness

Retail investors in India show increased interest in equities during lockdown

Even as fiscal year 2020 saw a sharp fall in the markets, an increasing number of fresh investors signed up to have demat accounts opened.

May 04, 2020 / 06:57 PM IST

In March and April this year, around 1.2 million new investors opened demat accounts with the Central Depository Services (CDSL) despite the ongoing nationwide lockdown, as per a report by The Economic Times. Meanwhile, the report noted that the month of April saw NSE internet trading volume rise by 53 percent.

This is an indication of more and more retail investors in the country taking to equities as against the more traditional forms of investments (say in bank deposits, gold, etc).

Even as fiscal year 2020 saw a sharp fall in the markets, an increasing number of fresh investors signed up to have demat accounts opened. This, at a time when economic activity in the country has been at a standstill due to the nationwide lockdown in light of the COVID-19 pandemic.

Track this blog for LIVE updates on the COVID-19 pandemic

"I think falling of markets, good IPOs, lockdown, all put together, increased the appeal of capital markets for people," said Prakarsh Gagdani, CEO,

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

He said, "From February to March, we saw an 80 percent growth in our customer acquisition, opened around 60,000 accounts in the month of March."

He also pointed out that a lot of their customers are those who are opening such accounts for the first time, seeing this is an opportunity to make money.

A report by Mint citing data from the Securities and Exchange Board of India said the number of new demat accounts opened during FY2020 stood at 4.9 million, a 22.5 percent increase from the 4 million demat accounts opened in FY2019. This, the report noted, was the highest in at least a decade.

Moneycontrol News
first published: May 4, 2020 06:57 pm